Pharma Serv Ventures Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 02-07-2024
- Paid Up Capital ₹ 1.03 M
as on 02-07-2024
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.80 Cr
as on 02-07-2024
- Revenue 27.85%
(FY 2023)
- Profit 11.27%
(FY 2023)
- Ebitda 286.06%
(FY 2023)
- Net Worth 2.83%
(FY 2023)
- Total Assets 2.89%
(FY 2023)
About Pharma Serv Ventures
The Corporate was formerly known as Enaltec Pharma Private Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.03 M.
The company currently has active open charges totaling ₹1.80 Cr.
Sameer Paigankar, Murali Sistla, and Darshak Shah serve as directors at the Company.
- CIN/LLPIN
U24233MH2007PTC171203
- Company No.
171203
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 May 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pharma Serv Ventures?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murali Sistla  | Director | 07-Nov-2008 | Current |
| Darshak Shah | Director | 29-May-2007 | Current |
| Sameer Paigankar | Director | 29-May-2007 | Current |
Financial Performance and Corporate Structure Insights of Pharma Serv Ventures.
Pharma Serv Ventures Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.85% increase. The company also saw a substantial improvement in profitability, with a 11.27% increase in profit. The company's net worth moved up by a moderate rise of 2.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharma Serv Ventures?
In 2023, Pharma Serv Ventures had a promoter holding of 99.61% and a public holding of 0.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nutragenix Healthcare Private LimitedActive 7 years 8 monthsSameer Paigankar, Murali Sistla and 1 more are mutual person
Lavue Pharmaceuticals Private LimitedActive 15 years 2 monthsSameer Paigankar, Murali Sistla and 1 more are mutual person
Pharma-Serv Healthcare Private LimitedActive 20 years 6 monthsSameer Paigankar, Murali Sistla and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 Sep 2019 | ₹1.80 Cr | Open |
How Many Employees Work at Pharma Serv Ventures?
Unlock and access historical data on people associated with Pharma Serv Ventures, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharma Serv Ventures, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharma Serv Ventures's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
